Geography matters. Community matters. 𝙔𝙤𝙪 matter. Community is at the heart of everything that we do at BioBuzz. 🧡 Which is why we’re thrilled to showcase the community that continues to drive us to do what we do 𝗲𝗮𝗰𝗵 𝗮𝗻𝗱 𝗲𝘃𝗲𝗿𝘆 𝗱𝗮𝘆 with the launch of our Weekly Takeovers in Philly this September. Every week a new ambassador, community member, or ecosystem friend, will “takeover” our Greater Philadelphia showcase page. 🎉 They'll "own" the page for the week as they buzz about themselves, the incredible people around them, the work they’re doing and supporting, and the things that they’re passionate about. 𝗘𝘅𝗰𝗶𝘁𝗲𝗱? So are we. 𝗜𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗲𝗱? Sign up today: https://lnkd.in/eiRdEKdc 𝗞𝗻𝗼𝘄 𝘀𝗼𝗺𝗲𝗼𝗻𝗲 𝘁𝗵𝗮𝘁'𝗱 𝗯𝗲 𝗮 𝗴𝗼𝗼𝗱 𝗳𝗶𝘁? TAG them below. 𝘗𝘭𝘦𝘢𝘴𝘦 𝘯𝘰𝘵𝘦 𝘵𝘩𝘢𝘵 𝘸𝘦 𝘬𝘪𝘯𝘥𝘭𝘺 𝘳𝘦𝘲𝘶𝘦𝘴𝘵 𝘵𝘩𝘢𝘵 𝘺𝘰𝘶 𝘭𝘪𝘷𝘦 𝘰𝘳 𝘸𝘰𝘳𝘬 𝘸𝘪𝘵𝘩𝘪𝘯 𝘵𝘩𝘦 𝘳𝘦𝘨𝘪𝘰𝘯 𝘢𝘯𝘥 𝘢𝘳𝘦 𝘸𝘪𝘵𝘩𝘪𝘯 𝘰𝘳 𝘴𝘶𝘱𝘱𝘰𝘳𝘵 𝘵𝘩𝘦 𝘭𝘪𝘧𝘦 𝘴𝘤𝘪𝘦𝘯𝘤𝘦𝘴. 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀? Message Cat, Annabel, Bryan or Joshua. #lifesciences #biotech #pharma #CGT #philly #community #biobuzz
BioBuzz - Greater Philadelphia
Technology, Information and Media
Philadelphia , PA 2,838 followers
The business of biotech 𝒍𝒐𝒄𝒂𝒍𝒊𝒛𝒆𝒅. Everything you know and love about BioBuzz... in Greater Philadelphia.
About us
BioBuzz’s mission is simple: to be more connected. Our regionally-focused storytelling, programs, events, and experiences connect, amplify and create impact across the life science workforce in growing biohubs. From University City to the Navy Yard to King of Prussia and beyond, this showcase page, well, showcases it all in and around Greater Philadelphia. Don't worry, you can still enjoy all the BioBuzz things via our parent page (@BioBuzz) while taking a deeper dive into the local Philly ecosystem here. Dig in with our regional news coverage, attend our events, join our community (https://app.biobuzz.io/join), or work with us (https://biobuzz.io/work-with-us/).
- Website
-
https://biobuzz.io/philadelphia-life-sciences-hub/
External link for BioBuzz - Greater Philadelphia
- Industry
- Technology, Information and Media
- Company size
- 2-10 employees
- Headquarters
- Philadelphia , PA
- Founded
- 2009
- Specialties
- life sciences, biotechnology, career development, professional development, networking, biotech jobs, pharma jobs, news, and employer branding
Updates
-
🚨BioLabs Philadelphia is excited to announce they've extended the deadline for Investor Day to FRIDAY at midnight! APPLY NOW AND SPREAD THE WORD: https://lnkd.in/ekhwc3KH
Okay, we heard you — it's been a tough couple weeks. So we're excited to announce that we're extending the deadline for Investor Day to FRIDAY at midnight! #biolabsinvestorday APPLY NOW AND SPREAD THE WORD: https://lnkd.in/ekhwc3KH
-
-
Start your morning off right.
Join Celerion for a networking breakfast event on March 13 from 9-10 a.m. here at the PABC to learn about how to prepare for first-in-humane clinical studies! 🔗Register by emailing [email protected]
-
-
BioBuzz - Greater Philadelphia reposted this
Our CEO Chris Frew spoke with Outsourced Pharma about flexible hiring for #biopharma and #CDMO - how do you see our marketplace model impacting the field?
We need a flexible #hiring marketplace – a new ecosystem – to generate increased awareness by professionals and students of positions in the #biopharma industry. “It’s no longer about simply posting full-time jobs,” says Chris Frew Frew, founder/CEO of BioBuzz Networks. But wow, is “fractional hiring” what you want at your CDMO? https://lnkd.in/eCZkTMbq
-
🚨 Don't forget—TONIGHT is the night! Philadelphia's life sciences leaders are gathering at Quorum at uCity Square for an essential industry-focused event hosted by Philly Builds Bio+. 📅 Tuesday, March 11, 2025 ⏰ 5:00 PM – 8:00 PM 📍 3675 Market Street, Philadelphia, PA 19104 This must-attend event will provide critical insights into the economic, scientific, and policy forces shaping 2025, and what they mean for investment, innovation, and the future of biotech. Link to register: https://lnkd.in/eriaaKA2 See you there!
-
🚨BioBuzz's Philadelphia Regional Roundup from Last Week 💰OPS & FINANCE >> Azzur Group: Sells Consulting Business to ELIQUENT Life Sciences for $56M. >> Ocugen: Reports Q4 & Full Year 2024 Financials. >> TEVOGEN BIO: Secures $8M in Non-Dilutive Grant Funding. 🧬CLINICAL & RESEARCH >> The Wistar Institute: Identifies New Target in Brain Cancer. >> Ocugen: EMA Backs ATMP Classification for OCU410 & OCU410ST. >> Integral Molecular: Bispecific Antibody Advances to Clinical Trials. >> Medicus Pharma Ltd.: Positive Phase 2 Data for Basal Cell Carcinoma Treatment. 👥 WORKFORCE & RECOGNITION >> SparingVision: Appoints Anjeza Gjino as CFO. >> Louis Kassa: Named to Philadelphia Business Journal’s Power 100. Full roundup: https://lnkd.in/e9V7WnfV Signup here: https://lnkd.in/easuWtKX
-
🚀 Mineralys Therapeutics, Inc. Therapeutics Hits Major Milestone with Promising Blood Pressure Drug Results! 🚀 Radnor, PA-based Mineralys Therapeutics is making strides in the battle against uncontrolled and resistant hypertension. Their experimental drug, lorundrostat, has delivered impressive results in two pivotal trials, significantly lowering blood pressure in patients who haven't had success with current treatments. In one Phase 3 trial, lorundrostat showed a 12-point reduction in blood pressure after 12 weeks—an exciting development for those suffering from hard-to-treat hypertension. This success, coupled with positive outcomes in a Phase 2 study, has analysts calling lorundrostat a “derisked, almost-commercial stage cardiometabolic asset.” The company is gaining investor confidence, with shares climbing 44% after the announcement, and analysts are forecasting strong potential for the drug to transform the treatment landscape for hypertension. Source: BioPharma Dive Article: https://lnkd.in/ens_m3nj
-
Congrats to the team at Merlin Biotech
The Alliance for Health Equity Receives Donation for Catalytic Impact Fund - $100,000 will be used to purchase shares in Merlin Biotech, a pharmaceutical firm dedicated to developing cancer treatments, including therapies for Ewing’s Sarcoma, a rare pediatric cancer. https://lnkd.in/dKsr2H6
-
-
A very important conversation to have tomorrow at University City Science Center with Builds Bio+. Come out and join us.
We’re one day away from a critical conversation on the future of life sciences in Philadelphia! With major policy shifts unfolding in Washington, federal funding changes could reshape academic research, commercialization, and Philly’s position as a biotech leader. What’s at stake for innovation and investment in our region? Join Philly Builds Bio+ tomorrow at Quorum at University City Science Center to be part of the discussion. Speakers include: Jennifer Gilburg, Deputy Secretary of Technology and Entrepreneurship Deputy Secretary of Technology and Entrepreneurship, Pennsylvania Department of Community & Economic Development. Rebecca L Grant, DVM, Senior Director, Life Sciences & Innovation, Department of Commerce | City of Philadelphia Sandhya Kortagere, PhD, Professor, Department of Microbiology & Immunology, Drexel University College of Medicine Dean Miller, MBA, CEO & President, Philadelphia Alliance for Capital and Technologies (PACT) Stephen Nappi, Associate VP, Technology Commercialization and Business Development, Temple University Heather A. Steinman, PhD, MBA, SVP Business Development, Executive Director, The Wistar Institute Nancy J Kelley, President & CEO, Nancy J Kelley + Associates, Founding Member, Builds Bio+ Mitchel Simpler, Partner Emeritus, Jaros, Baum & Bolles, Found Member, Builds Bio+ After the program, stay for a high-impact networking reception to connect with some of the most influential voices in the industry. Register today: https://lnkd.in/eriaaKA2 #BuildsBio #LifeSciences #Innovation #EconomicDevelopment #Networking #PhillyBuildsBio
-
-
Bob Castellucci joins PQE Group as Principal Consultant and Networking Executive! PQE continues to expand its US business as a Complete Quality Solution provider for GCP, GLP, GMP & GDP. You can also come out and meet Bob in a few weeks at the next BioBuzz event on May 18th at the University City Science Center Quorum event space. https://lnkd.in/evEmhtU5